The Sickle Cell Center Of The Commonwealth Of Penna is categorized under Medical Research in Philadelphia, PA and active since 2010.
The Sickle Cell Center Of The Commonwealth Of Penna was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 700 Spruce St, Philadelphia, Pennsylvania PA 19106 or by phoning (215) 829-5391. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | The Sickle Cell Center Of The Commonwealth Of Penna |
Address: | 700 Spruce St, Philadelphia, Pennsylvania 19106 |
Phone Number: | (215) 829-5391 |
Annual Revenue (USD): | $0 to $49.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
The Sickle Cell Center Of The Commonwealth Of Penna was started in 2010 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact for inquiries that concern The Sickle Cell Center Of The Commonwealth Of Penna by calling the company number (215) 829-5391, as your correspondence is most welcome. Additionally, the physical location of the single location of The Sickle Cell Center Of The Commonwealth Of Penna can be found at the coordinates 39.945455,-75.153393 as well as the street address 700 Spruce St in Philadelphia, Pennsylvania 19106.
For its online presence, you may visit The Sickle Cell Center Of The Commonwealth Of Penna’s website at and engage with its social media outlets through on Twitter and on Facebook.